Consistently, the efficacy of V9 antibody treatment in obese mice was evident in the reduced rate of tumor growth (Fig. 4F), tumor size (Fig. 4G), tumor weight (Fig. 4H) and reduced ALDH1 activity in tumor cells (Fig. 4I). The gene discussed is ALDH1A1; the disease is neoplasm.